Physician profile
Shane A Maxwell
NPI 1508825456
$6,274.22
in general payments reported to CMS, 2019-2025
46 companies · $1,446 in 2025
The $1,446 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $572 · 2021: $645 · 2022: $829 · 2023: $782 · 2024: $1,105 · 2025: $1,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,332.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,964.17 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Abbvie INC. | $609.85 | 2021-2025 | |
| Spinefrontier, INC. | $424.77 | 2025 | Facetfuse, Nanofuse, Sijfuse |
| Collegium Pharmaceutical, INC. | $285.21 | 2019-2025 | Belbuca |
| Allergan, INC. | $230.07 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $200.74 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $191.42 | 2023-2025 | Dysport |
| Supernus Pharmaceuticals, INC. | $182.07 | 2019-2020 | |
| Hydrocision, INC. | $175.28 | 2024-2025 | Tenjet |
| Abbott Laboratories | $164.52 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $161.88 | 2022 | |
| Stimwave Technologies Incorporated | $130.50 | 2019-2022 | |
| Averitas Pharma INC. | $114.45 | 2024-2025 | Qutenza |
| Biodelivery Sciences International, INC. | $101.18 | 2020-2021 | |
| Medtronic, INC. | $95.82 | 2023-2024 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $88.05 | 2023-2024 | Evoke, Evoke Scs |
| Pfizer INC. | $77.57 | 2021-2024 | |
| Amgen INC. | $74.82 | 2019-2022 | |
| Spinal Simplicity, LLC | $71.46 | 2021-2024 | Ha Minuteman G3-R |
| Curonix LLC | $70.78 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Piramal Critical Care | $62.88 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.62 | 2022 | |
| Scilex Pharmaceuticals INC. | $56.82 | 2020-2023 | Ztlido |
| Merz Pharmaceuticals, LLC | $55.41 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $47.62 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $44.03 | 2021 | |
| Lilly USA, LLC | $43.18 | 2021-2022 | |
| Pacira Therapeutics, INC. | $43.06 | 2019-2020 | |
| Ns Pharma, INC. | $41.36 | 2023 | Viltepso |
| Ptc Therapeutics, INC. | $39.02 | 2019 | |
| Itf Therapeutics LLC | $32.94 | 2025 | |
| Eisai INC. | $31.70 | 2021 | |
| Avanos Medical | $31.05 | 2024 | Standard Rf Disposables |
| Painteq LLC | $30.34 | 2022-2023 | Painteq |
| Amneal Pharmaceuticals LLC | $30.00 | 2022 | |
| Saol Therapeutics INC. | $28.79 | 2019 | |
| Alnylam Pharmaceuticals INC. | $26.62 | 2019-2022 | |
| Stryker Corporation | $24.85 | 2025 | Insignia, Accolade, Triathlon |
| Radius Health, INC. | $21.37 | 2021 | |
| Nalu Medical, INC. | $19.92 | 2022 | |
| Medtronic USA, INC. | $19.69 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.40 | 2021 | |
| Lundbeck LLC | $16.01 | 2022 | |
| Si-Bone, INC. | $15.47 | 2022 | |
| Redhill Biopharma INC. | $11.78 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.